LSX Nordic Congress

🔎 Did you know that 50% of the investors attending the LSX Nordic Congress are from outside the Nordic and Baltic regions?   This is your chance to expand your network and connect with over 200 regional and international investors.   Curious about what they're looking to invest in? See the stats below Looking to join them? Find out more https://lnkd.in/eCkHc4Rq #LSXNordic

As we approach the LSX Nordic Congress, we are excited to offer you a sneak peek into the insightful discussions and perspectives that will be shared at the event.   Join us as Ingrid Teigland Akay, Managing Partner at Hadean Ventures, shares her thoughts on the current funding landscape and explores the exciting opportunities available for life science companies. Don't miss Ingrid's session, "Northern Horizons: Navigating the Nordic Biotech Investment Frontier in 2024 and Beyond," on Day 1 (8th October) at 11:50 AM. Find out more: https://lnkd.in/g8Kf2FKU

📣 Our AI Future is Now - Utilising Gen AI & LLMs to Solve Healthcare Challenges Join our panel of #MedtechLeaders & #HealthtechLeaders as they discuss: ·  Leveraging generative AI tools & large language models to solve unmet medical needs and optimise care delivery ·  EU AI Act – How will this legislation affect digital health and medtech companies? · AI use to improve the patient and consumer experience – what about less obvious use cases for AI? ·  Managing consumer and patient expectations in the age of AI ·  Effective safeguards for responsible AI use (ethical frameworks, diversity & inclusion in AI development etc.) 🎙 Hear from: ·  Farzaneh Etminani, AI Strategist, Region Halland ·  Lauri Sippola, Co-founder & CEO, Gosta Labs ·  Jussi Leinonen, Strategic Project Lead, Bayer ·  Henriikka Halinen, Business Leader, Emergency Care, Western Europe, Philips Find out more: https://lnkd.in/eJ_gUeqn #LSXNordic 

📣 Nordic Biotechs Beyond Borders:  Public-Stage Nordic Biotech’s in Today's Markets Join our panel of #BiotechLeaders as they discuss: ·  The current state of the public markets ·  Effective strategies for Nordic biotechs to enter and establish a foothold in new international markets, including considerations for regulatory compliance and cultural nuances ·  The importance of building robust global networks and partnerships, exploring how collaborations with international stakeholders contribute to market access, distribution, and product adoption. ·  How public stage Nordic biotechs can navigate the complexities of sustaining growth, maintaining innovation momentum, and meeting the expectations of shareholders and the broader market post-IPO ·  How strategic partnerships and collaborations contribute to market presence, product development, and overall competitiveness 🎙 Hear from: ·  Renee Aguiar-Lucander, CEO, Calliditas Therapeutics ·   Jens Lindberg, CEO, Medivir AB ·   Per Andersson, CEO, XSPRAY PHARMA AB (PUBL) ·   Søren Bregenholt, CEO, Alligator Bioscience AB Find out more: https://lnkd.in/eNv8WG2k #LSXNordic #Biotech

Before you log off for the summer, lock in the best available price for the LSX Nordic Congress! Curious about who you'll be connecting with? See who is already joining here - https://lnkd.in/eMxvuknQ Secure your spot today - https://lnkd.in/e37TMufY Join us at the forefront of life sciences in the Nordic and Baltic region #LSXNordic #LifeScience #Investment

This year the LSX Nordic Congress is bringing more opportunities than ever before to connect, collaborate, and form lasting relationships with life science innovators and leaders across Northern Europe, as well as international investors! This year's agenda will be looking at the growth and internationalisation of the Nordic region and its transformation into a global hub of innovation. 90+ speakers have already been confirmed including global heads at AstraZeneca, Novo Nordisk, and Genmab and international investors from Forbion, Sunstone Life Science Ventures, and Novo Venture. You can also get involved in: • Networking Drinks: Providing you with the opportunity to informally network and build relationships with key figures in the Northern European life science community • Qualified partnering: Pre-arrange private meetings with your preferred participants ahead of the event with our user-friendly conference partnering platform. Search, filter, and auto-schedule to build your personal itinerary with ease • Showcases: These sessions are designed to highlight Nordic innovation and investment opportunities from across the region. If you're fundraising there's no better place to be, you'll have access to 150+ specialist life science investors Secure the best rate, and book before 28 June to save up to €650. Find out more - https://lnkd.in/eCkHc4Rq #LSXNordic #Biotech #Medtech #healthtech #pharma #investors

🌟 Thank you to all who joined LSX Nordic Congress 2023! 🌟 It was truly inspiring to see industry leaders, budding entrepreneurs, and visionary investors come together to shape the future of life sciences. A HUGE thank you to all who joined us, sharing their invaluable insights, pioneering research, and investment perspectives. We'd like to extend a special mention to our sponsors - Platinum Sponsors - Back Bay Life Science Advisors - Nasdaq Local Host Sponsors - BioInnovation Institute - Lundbeckfonden / Lundbeck Foundation - Novo Nordisk Foundation Gold Sponsors - Coulter Partners - Mintz - NDA Group AB Silver Sponsors - AWA - MSC Nordics - Sterne, Kessler, Goldstein & Fox International Investor Sponsors - Danish Ministry of Foreign Affairs - Export and Investment Fund of Denmark Bronze Sponsors - Biobridge Partners - GenScript - Porton Pharma Solutions Ltd. - OPIS - Raybow Your support and contributions were integral in creating a memorable experience for our attendees. We look forward to welcoming everyone back next year! #LSXNordic #LifeSciences #Business #Investment

Interesting discussions today at the LSX Nordic Congress where Andreas Holm Mattsson, founder and Chief AI Officer at Evaxion Biotech A/S, joined a panel to discuss "How Artificial Intelligence Is Shaping The Future Of Drug Discovery, Design, And Development". Joining Andreas were Alex Zhavoronkov, Founder and CEO of Insilico Medicine and Tom Gibbs, Senior Investment Manager at Debiopharm Investment SA and the session was ably chaired by Marko Kuisma from Innovestor

The panel discussion at the LSX Nordic Congress, featuring Thomas T., on "Beyond The Double Helix: Boldly Advancing The Future Of Cell And Gene Therapies," offered inspiring insights into the future of medical science. #LSXNordicCongress #CellAndGeneTherapies #FutureOfMedicine Sound Bioventures